Mikhail Blagosklonny has cemented his status as a leading specialist in cancer therapy and research and therapy. His extensive knowledge and vast experience have immensely contributed to the medicine world, as well as earning him respect and admiration from peers.
Blagosklonny’s role at the Roswell Park Cancer Institute
Mikhail Blagosklonny has become the latest high-profile employee at the Roswell Park Cancer Institute. The prestigious institution has deemed it necessary to enlist the services of the accomplished doctor in their quest to revolutionizing cancer research and treatment.
At the center, he is tasked with offering invaluable advice and skills needed for the advancement of cancer research. Additionally, he is also expected to lecture young minds as they navigate the turbulent medicine world. Having written a variety of novels, he is tasked with applying his molecular and cellular research into real-life scenarios within the parameters of clinical trials.
By joining an elite team of specialists, Mikhail Blagosklonny is expected to positively contribute to the generation of ideas related to cell protection from anticancer drugs and chemotherapy. Consultative discussions among the highly talented experts are expected to rapidly facilitate the identification of viable treatment modules.
Publications Edited By Blagosklonny
His editorial skills have been put to test as an Editor-in-chief at Oncotarget. The online magazine site aims at polishing the literary works of various authors before submission to the public. Such editorial services are essential in safeguarding the quality of reading content available to readers. The site specializes in different academic fields such as gerotarget, endocrinology, immunology and cardiology.
According to Impact Journals, Mikhail Blagosklonny has also shifted focus to the Cell Cycle, a detailed biweekly journal focusing on cell biology. As Editor-in-Chief, he offers invaluable advice on pitfalls to avoid as upcoming medical authors as well as polishing their research skills.
Blagosklonny’s Hypothesis about the Role of TOR Signaling in Aging and Cancer
As an accomplished researcher and specialist, Mikhail Blagosklonny has delved into the relationship between TOR signals and Cancer in patients. According to him, protein synthesis directly contributes to muscle mass growth and prolonged resistance to insulin.